{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Grover Beach",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80674",
      "recalling_firm": "H J Harkins Company Inc dba Pharma Pac",
      "address_1": "1400 W Grand Ave Ste F",
      "address_2": "N/A",
      "postal_code": "93433-4221",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to a physician's office.",
      "recall_number": "D-1022-2018",
      "product_description": "Valsartan tablets 160 mg, 90-count bottle, Rx Only, Repackaged by H.J. Harkins Co, Inc. Grover Beach, CA 93433, NDC 43547-0369-09.      Tablet is yellow, capsule-shaped, biconvex, film-coated tablets debossed with  343  on one side and  HH  on the other side.",
      "product_quantity": "540 tablets",
      "reason_for_recall": "Carcinogen impurity detected in API used to manufacture drug product.",
      "recall_initiation_date": "20180726",
      "center_classification_date": "20180801",
      "termination_date": "20190118",
      "report_date": "20180808",
      "code_info": "Lot # VSA000OV   Manufacturer's original lot # 343B17015, exp date 02/19  NDC 43547-0369-09"
    }
  ]
}